Paradigm Capital reports 4.42% stake in Integra LifeSciences
Integra LifeSciences Holdings Corp’s common stock has a reported significant shareholder, Paradigm Capital Management, Inc., as updated in an amended ownership report.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Integra LifeSciences Holdings Corp’s common stock has a reported significant shareholder, Paradigm Capital Management, Inc., as updated in an amended ownership report. Paradigm Capital Management, a New York S corporation based in Albany, reports beneficial ownership of 3,439,098 shares of Integra LifeSciences common stock.
This position represents 4.42% of the outstanding common stock of Integra LifeSciences. Paradigm Capital Management reports sole power to vote and dispose of all 3,439,098 shares, with no shared voting or dispositive power. The filing characterizes the holding as ownership of 5 percent or less of the class, reflecting its current status relative to regulatory reporting thresholds.
Key Figures
Key Terms
beneficially owned financial
sole power to vote financial
sole power to dispose financial
Ownership of 5 percent or less of a class regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What type of entity is Paradigm Capital Management in relation to its Integra LifeSciences (IART) holdings?
How does the filing describe Paradigm Capital Management’s ownership level in Integra LifeSciences (IART)?
AI-generated analysis. How Rhea-AI works. Not financial advice.